Production of hybrid bispecific antibody recognizing human colorectal carcinoma and CD3 antigen.

Molecular biotherapy Pub Date : 1992-03-01
J Xiang, Z Pan, S Attah-Poku, L Babiuk, Y Zhang, E Liu
{"title":"Production of hybrid bispecific antibody recognizing human colorectal carcinoma and CD3 antigen.","authors":"J Xiang,&nbsp;Z Pan,&nbsp;S Attah-Poku,&nbsp;L Babiuk,&nbsp;Y Zhang,&nbsp;E Liu","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The present study reports on the use of gene transfer by vector DNA in the generation of hybrid hybridoma, the quadroma secreting the hybrid bispecific antibody. A quadroma B72.3neo/OKT3gpt was simply derived from the fusion of two hybridoma cell lines, B72.3 and OKT3, tagged with vector DNA mpSV2neo and mpSV2gpt, respectively, and selected in the media containing both G418 and mycophenolic acid. The hybrid bispecific antibody B72.3/OKT3 was purified from the quadroma ascites by the use of hydroxylapatite column on high-pressure liquid chromatography. This bispecific antibody contained one binding site for the TAG72 antigen on OVCAR3 tumor cells and the other binding site for the CD3 molecule on human T cells. It was able to target human T lymphocytes to significantly lyse the human ovarian cancer cells and may therefore be useful in immunotherapy of cancer.</p>","PeriodicalId":18809,"journal":{"name":"Molecular biotherapy","volume":"4 1","pages":"15-23"},"PeriodicalIF":0.0000,"publicationDate":"1992-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular biotherapy","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The present study reports on the use of gene transfer by vector DNA in the generation of hybrid hybridoma, the quadroma secreting the hybrid bispecific antibody. A quadroma B72.3neo/OKT3gpt was simply derived from the fusion of two hybridoma cell lines, B72.3 and OKT3, tagged with vector DNA mpSV2neo and mpSV2gpt, respectively, and selected in the media containing both G418 and mycophenolic acid. The hybrid bispecific antibody B72.3/OKT3 was purified from the quadroma ascites by the use of hydroxylapatite column on high-pressure liquid chromatography. This bispecific antibody contained one binding site for the TAG72 antigen on OVCAR3 tumor cells and the other binding site for the CD3 molecule on human T cells. It was able to target human T lymphocytes to significantly lyse the human ovarian cancer cells and may therefore be useful in immunotherapy of cancer.

识别人结直肠癌和CD3抗原的杂交双特异性抗体的制备。
本研究报道了利用载体DNA进行基因转移,产生分泌杂交双特异性抗体的杂交杂交瘤。B72.3neo/OKT3gpt是由两个杂交瘤细胞系B72.3和OKT3融合而成,分别用载体DNA mpSV2neo和mpSV2gpt标记,并在含有G418和霉酚酸的培养基中选择。采用高压液相色谱羟基磷灰石柱分离纯化了quadroma腹水的杂交双特异性抗体B72.3/OKT3。该双特异性抗体在OVCAR3肿瘤细胞上含有一个与TAG72抗原结合的位点,在人T细胞上含有另一个与CD3分子结合的位点。它能够靶向人T淋巴细胞显著地溶解人卵巢癌细胞,因此在癌症的免疫治疗中可能是有用的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信